Amerikanische Gesellschaft für Hirudotherapie

Cervical Radiculopathy

Off-label use with one RCT (Michalsen 2018) showing significant pain reduction at 7 days in cervical radiculopathy without surgical indication.

Tier B — RCT-supported off-labelOff-Label untersuchtLast updated: 2026-05-26 · Reviewed by ASH Editorial Board

Patienten-Zusammenfassung

Ist dies FDA-zugelassen fuer diese Anwendung?
No — investigated off-label. The FDA cleared medicinal leeches in 2004 only for venous congestion in microsurgical reconstruction (K040187). Use for cervical radiculopathy is supported by one published trial but not FDA-evaluated.
Welche Evidenz existiert?
One randomized trial (Michalsen 2018, n=66) reported that a single session of leech therapy reduced neck and arm pain at 7 days compared with conventional care, with benefit lasting at 4 weeks. The neck disability score also improved. This is a single small trial with short follow-up. Leech therapy is not appropriate when there is progressive weakness, severe nerve compression on imaging, or any sign of spinal cord involvement — those require urgent surgical evaluation.
Hauptrisiken
  • Bleeding and oozing from bite sites on the neck and shoulder for several hours
  • Bruising along the neck for 3 to 7 days, which can be cosmetically noticeable
  • Itching, redness, and irritation at bite sites for days to weeks
  • Small permanent scars on the neck or upper back
  • Local skin infection or, rarely, Aeromonas infection from leech gut bacteria
  • Allergic reaction to leech saliva (uncommon)
  • Temporary worsening of pain or stiffness for 1 to 2 days after the session
Wer dies nicht in Betracht ziehen sollte
  • Patients taking blood thinners such as warfarin, apixaban, rivaroxaban, dabigatran, or heparin
  • Patients with hemophilia or other inherited bleeding disorders
  • Patients with severe anemia (hemoglobin under 10 g/dL)
  • Patients with a weakened immune system
  • Patients with progressive arm weakness, hand clumsiness, or balance problems (surgical evaluation needed)
  • Patients with spinal cord compression on imaging (urgent surgical evaluation)
  • Patients with any sign of infection near the spine
Was Sie Ihren Kliniker fragen sollten
  • Have I had an MRI, and is there a structural problem that needs surgical evaluation first?
  • Am I a candidate for standard treatments — physical therapy, NSAIDs, epidural steroid injection — and have I given them a fair trial?
  • What is the realistic chance leech therapy will help me, and for how long?
  • What is the practitioner's experience with cervical-region leech application?
  • What antibiotic plan do you use for Aeromonas prevention?
  • What red flags should I and my family watch for after the session?
  • What is the cost, and is it covered by insurance? (typically not)
Wann dringende medizinische Versorgung suchen
  • New or worsening weakness in the arm or hand
  • New numbness, tingling, or weakness in the legs, balance problems, or loss of bladder/bowel control (possible spinal cord involvement — emergency)
  • Sudden severe neck pain with fever and stiff neck (possible spinal infection)
  • Bleeding from a bite site lasting more than 24 hours
  • Spreading redness, warmth, pus, or red streaks (cellulitis)
  • Fever above 38.0 C / 100.4 F or chills
  • Hives, throat tightness, or breathing difficulty

Was dies NICHT bedeutet

  • It does not mean leech therapy is FDA-approved for cervical radiculopathy — it is not.
  • It does not mean leech therapy fixes the underlying disc or bone problem — it may only reduce symptoms temporarily.
  • It does not mean it replaces neurosurgical evaluation when there are red-flag features such as progressive weakness or spinal cord signs.
  • It does not mean every patient improves — the published trial showed benefit on average, but individual responses vary.
  • It does not mean improvement is permanent — long-term outcomes beyond 4 weeks are not well studied.

Clinical Profile

Category
neurological
ICD-10
M50.10, M50.11, M50.12, M50.13, M54.12
Safety tier
medium

Evidence Summary

No randomized controlled trial or clinical study of leech therapy for cervical radiculopathy has been published. A proposed rationale, extrapolated from leech trials in other musculoskeletal pain syndromes, combines local anti-inflammatory effects with reduction of paravertebral venous congestion that may contribute to nerve-root edema, but this remains speculative. Use is investigational and is not a substitute for surgical evaluation in patients with progressive motor deficit.

Treatment specifics

How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: switch the audience selector in the top bar to “Clinician” to view protocol detail.)

Key Trials

  1. Michalsen A et al. (2018), n=66

Contraindications

  • Active anticoagulant therapy (warfarin INR >2.0, DOACs, heparin)
  • Hemophilia or other bleeding disorder
  • Severe anemia (Hb <10 g/dL)
  • Active bacteremia or sepsis
  • Known hypersensitivity to leech salivary proteins
  • Pregnancy (relative — first/third trimester)
  • Immunocompromised state with severe neutropenia
  • Progressive motor deficit (surgical referral)
  • Spinal cord compression on imaging
  • Active epidural infection

Related Conditions

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.

Cervical Radiculopathy — Hirudotherapy Evidence | ASH